Centrum Medyczne Komorniki Sp. z o.o.

The research team at Centrum Medyczne Komorniki is advancing treatments for a range of heart and vessel conditions, including Atherosclerotic Cardiovascular Disease, Elevated Lipoprotein(a), Heart failure with preserved ejection fraction and obesity, as well as Peripheral Arterial Disease. Ongoing studies evaluate novel agents that could lower cardiovascular risk, improve functional walking distance, and reduce hospital admissions.

• Innovative lipid‑lowering therapies
• Heart failure with preserved ejection fraction treatment strategies
• Functional outcome improvement in peripheral artery disease
• Reduction of major adverse cardiovascular events

With four dedicated investigators, the site provides patients access to cutting‑edge cardiovascular research while generating valuable data for the broader medical community.

At Centrum Medyczne Komorniki, researchers are focused on improving the lives of individuals with severe Chronic Obstructive Pulmonary Disease. Current work tests a new inhaled therapy designed to lower the frequency of exacerbations and enhance overall respiratory health.

• Inhaled anti‑inflammatory drug development
• Strategies to prevent COPD exacerbations
• Quality‑of‑life enhancements for severe respiratory patients
• Long‑term safety and efficacy assessments

The dedicated team of four investigators ensures rigorous patient monitoring and contributes important findings to global efforts against chronic lung disease.